Neza Sales Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 8.82 M
as on 17-11-2024
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 38.49 Cr
as on 17-11-2024
- Satisfied Charges ₹ 13.00 Cr
as on 17-11-2024
- Revenue %
(FY 2023)
- Profit -216.86%
(FY 2023)
- Ebitda -217.01%
(FY 2023)
- Net Worth -0.33%
(FY 2023)
- Total Assets -0.00%
(FY 2023)
About Neza Sales
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.82 M.
The company currently has active open charges totaling ₹38.49 Cr. The company has closed loans amounting to ₹13.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajib Saikia and Sajida Begum serve as directors at the Company.
- CIN/LLPIN
U51909AS2003PTC007107
- Company No.
007107
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 May 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Kamrup, Assam, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Neza Sales?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajib Saikia  | Director | 23-May-2003 | Current |
| Sajida Begum | Director | 12-Nov-2005 | Current |
Financial Performance of Neza Sales.
Neza Sales Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 216.86% decrease in profit. The company's net worth dipped by a decrease of 0.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neza Sales?
In 2022, Neza Sales had a promoter holding of 88.43% and a public holding of 11.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hayat Hospital Private LimitedActive 11 years 9 monthsRajib Saikia and Sajida Begum are mutual person
- Hayat Clinic And Diagnostics Private LimitedActive 5 years 10 months
Rajib Saikia is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Mar 2024 | ₹28.55 Cr | Open |
Others Creation Date: 13 Jan 2010 | ₹9.94 Cr | Open |
Assam Gramin Vikash Bank Creation Date: 29 Mar 2014 | ₹6.50 Cr | Satisfied |
How Many Employees Work at Neza Sales?
Unlock and access historical data on people associated with Neza Sales, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neza Sales, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neza Sales's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
